ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 165 filers reported holding ACORDA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $68,000 | -25.3% | 8,932 | +30.1% | 0.00% | 0.0% |
| Q1 2019 | $91,000 | -15.0% | 6,864 | 0.0% | 0.00% | -33.3% |
| Q4 2018 | $107,000 | -20.7% | 6,864 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $135,000 | -31.5% | 6,864 | 0.0% | 0.00% | -40.0% |
| Q2 2018 | $197,000 | +21.6% | 6,864 | 0.0% | 0.01% | +25.0% |
| Q1 2018 | $162,000 | +10.2% | 6,864 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $147,000 | +41.3% | 6,864 | +56.0% | 0.00% | +33.3% |
| Q3 2017 | $104,000 | +46.5% | 4,400 | +21.2% | 0.00% | +50.0% |
| Q2 2017 | $71,000 | +77.5% | 3,630 | +89.7% | 0.00% | +100.0% |
| Q1 2017 | $40,000 | +17.6% | 1,914 | +6.1% | 0.00% | 0.0% |
| Q4 2016 | $34,000 | – | 1,804 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
| DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
| Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
| Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
| DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
| Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
| Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
| Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
| Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |